Search Page
Save citations to file
Email citations
Send citations to clipboard
Add to Collections
Add to My Bibliography
Create a file for external citation management software
Your saved search
Your RSS Feed
Search Results
4 results
Filters applied: . Clear all
Page 1
Two or three year disease-free survival (DFS) as a primary end-point in stage III adjuvant colon cancer trials with fluoropyrimidines with or without oxaliplatin or irinotecan: data from 12,676 patients from MOSAIC, X-ACT, PETACC-3, C-06, C-07 and C89803.
Eur J Cancer. 2011 May;47(7):990-6. doi: 10.1016/j.ejca.2010.12.015. Epub 2011 Jan 21.
Eur J Cancer. 2011.
PMID: 21257306
Free PMC article.
Design of clinical trials for biomarker research in oncology.
Mandrekar SJ, Sargent DJ.
Mandrekar SJ, et al.
Clin Investig (Lond). 2011 Dec;1(12):1629-1636. doi: 10.4155/CLI.11.152.
Clin Investig (Lond). 2011.
PMID: 22389760
Free PMC article.
Item in Clipboard
Using cure models and multiple imputation to utilize recurrence as an auxiliary variable for overall survival.
Conlon AS, Taylor JM, Sargent DJ, Yothers G.
Conlon AS, et al.
Clin Trials. 2011 Oct;8(5):581-90. doi: 10.1177/1740774511414741. Epub 2011 Sep 15.
Clin Trials. 2011.
PMID: 21921063
Free PMC article.
Item in Clipboard
Comparison of continuous versus categorical tumor measurement-based metrics to predict overall survival in cancer treatment trials.
An MW, Mandrekar SJ, Branda ME, Hillman SL, Adjei AA, Pitot HC, Goldberg RM, Sargent DJ.
An MW, et al.
Clin Cancer Res. 2011 Oct 15;17(20):6592-9. doi: 10.1158/1078-0432.CCR-11-0822. Epub 2011 Aug 31.
Clin Cancer Res. 2011.
PMID: 21880789
Free PMC article.
Item in Clipboard
Cite
Cite